Eric Easom - 08 Nov 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Issuer symbol
ANTX
Transactions as of
08 Nov 2022
Transactions value $
-$267,794
Form type
4
Filing time
09 Nov 2022, 19:33:32 UTC
Previous filing
07 Nov 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale -$89.4K -5.8K -26.28% $15.41 16.3K 08 Nov 2022 Direct F1
transaction ANTX Common Stock Sale -$20.6K -1.26K -7.71% $16.38 15K 08 Nov 2022 Direct F1
transaction ANTX Common Stock Sale -$158K -10.1K -67.33% $15.61 4.91K 09 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.